Aristotle University Of Thessaloniki (AUTH)
Μελέτη του βιολογικού ρόλου και των μοριακών αλληλεπιδράσεων μιας νέας οικογένειας πρωτεϊνικών κινασών που φωσφορυλιώνουν επαναλαμβανόμενες αλληλουχίες αργινίνης-σερίνης
Abstract
dc:descriptionSerine/arginine protein kinases (SRPKs) represent a novel class of enzymes that specifically modify SR or RS dipeptide motifs. In the present thesis we studied the biological role and molecular interactions of a new member of the SRPK family, named SRPK1a. SRPK1a is an alternatively spliced form of SRPK1 and contains an insertion of 171 amino acids at its NH2-terminal domain. This additional sequence of SRPK1a contains a relatively high number of proline residues and two LXXLL motifs (148LAPLL152 and 158LGRLL162), which are thought to facilitate the interaction of different proteins with nuclear receptors. Using the yeast two-hybrid assay, we found that the extended NH2-terminal domain of SRPK1a interacts with the p53 tumor suppressor protein and with Scaffold Attachment Factor-B1, a nuclear scaffold-associated protein that interacts with specific DNA sequences, designated as Matrix Attachment Regions (MARs). Confirmation of the first interaction (SRPK1a with p53) was provided by in vitro pull-down assays, while the second interaction (SRPK1a with SAF-B1) was confirmed by in vitro binding assays, as well as by co-immunoprecipitation from 293T cells doubly transfected with SRPK1a and SAF-B1. Since SAF-B1 and p53 do not contain any RS dipeptides and therefore are not phosphorylated by SRPK1a, we searched for a new molecule linking SAF-B1, p53 and SRPK1a. Our research led us to the identification of P2P-R, a member of the proliferation potential proteins (P2P) that was previously shown to bind p53. P2P-R contains an RS domain that is targeted by SR protein kinases and especially by SRPK1a. Using GST-pulldown and co-immunoprecipitation assays we found that P2P-R also interacts, via its RS region, with SAF-B1. Moreover, both SAF-B1 and P2P-R were found to associate with the DNAse resistant nuclear matrix. In a following step, we showed that both SAF-B1 and P2P-R act as co-repressors of estrogen induced transcription and function as part of the estrogen receptor transcription complex together with estrogen receptor α, steroid receptor co-activator 1 (SRC-1) and co-activator associated arginine methyltransferase (CARM1). Using deletion analysis we found that the repressional activity of P2P-R is confined to its C-terminal most segment (amino acids 1314-1516). Furthermore, using differential cell extraction procedures, we showed that addition of the ERα ligand, estradiol or its antagonist tamoxifen, results in the translocation of a significant part of the receptor to the nuclear matrix fraction. This translocaton coincides with a raise in SR protein kinase activity in the same fraction. Most notably, SRPK1a positively influences estrogen induced transcription. Taken together our observations suggest that nuclear matrix entities influence estrogen-dependent transcription and SRPK1a may modulate the interactions among the components of the estrogen receptor regulatory complex and/or the nuclear matrix, in a manner that leads to transcriptional activation. In addition, we performed studies in HepG2 cells, in collaboration with Dr Hadzopoulou’s group, demonstrating that overexpression of SRPK1a activates HNF-4α-mediated transcription. An SR protein kinase activity was shown to associate tightly with HNF-4α. PGC-1 (PPAR γ Coactivator 1) is the major co-activator of hepatocyte nuclear factor-4α and possesses several repeats of RS dipeptides that are phosphorylated mainly by SRPK1a, and to a lesser extent by SRPK1. In line with this observation, SRPK1a was shown to bind PGC-1 with a much higher affinity than SRPK1. The RS domain of PGC-1 was responsible for this interaction, since GST-PGC-1-ΔRS (a mutant form, lacking the entire RS domain) could not be targeted by the kinase. Overexpression of PGC-1 activates HNF-4α-dependent transcription, whereas the transactivation potential of its mutant form (PGC-1-ΔRS), lacking the RS domain, was reduced by 50%. It is not yet clear whether -and to what extent- the activation of HNF-4α-dependent transcription, by SRPK1a, is mediated by phosphorylation of the RS domain of PGC-1, since SRPK1a is able to impact transcription, even when HepG2 cells were transfected with PGC-1-ΔRS. Finally, in contrast with the estrogen receptor, HNF-4α localization was restricted to the nucleoplasmic fraction of HepG2 cells and there is no evidence for an HNF-4α-based transcriptional complex associated with the nuclear matrix. In agreement with those observations overexpression of SAF-B1 results in a mild repression of HNF-4α-induced transcription.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Peidis, Philippos
- Πεΐδης, Φίλιππος
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/20056